BALAXI PHARMACEUTICALS LIMITED

Web: balaxiventures.in NSE: BALAXI SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

26 0(-1%)

Volume

32k as on 23, Jun

Open

High

Low

VWAP

52 Week High

52 Week Low

Viand Research Rating

Quality Score

0/100

Growth Score

23/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

141

No. of Shares

5.52

P/E

P/B

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

ROCE

Profit Growth

Listing Date

30-Nov-15

Promoter Holding

65.99%

FII Holding

DII Holding

2.56%

Price Chart

Price Performance

1 Week4%

1 Month10%

3 Months17%

6 Months17%

1 Year17%

YTD17%

Moving Average

5 Day SMA23

10 Day SMA23

20 Day SMA24

30 Day SMA25

50 Day SMA0

61 Day SMA0

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	25	23	25	25
Resistance 2	25	23	24	25
Resistance 1	24	23	24	24
Pivot Point	23	23	23	23
Support 1	23	23	23	23
Support 2	22	23	23	22
Support 3	21	23	22	21

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 65.99%	(0.01) 65.99%	(0.01) 65.99%	(0.01) 65.99%	(0.01) 65.99%	(0.01) 65.99%	(0.01) 65.99%	(-0.91) 65.99%	(-4.41) 66.86%	(0.01) 71.22%	(0.01) 71.22%	(-0.31) 71.22%	(-1.11) 71.57%	(-0.21) 72.69%	(0.01) 72.86%	(0.01) 72.86%	(0.01) 72.86%	(0.01) 72.86%	(0.01) 72.86%
FIIs	(-1.71) 0.00%	(-1.81) 1.74%	(-5.41) 3.50%	(-7.21) 8.87%	(-0.51) 16.02%	(0.01) 16.48%	(-0.41) 16.48%	(-0.31) 16.88%	(-1.41) 17.21%	(0.01) 18.57%	(0.01) 18.57%	(-0.11) 18.57%	(-0.31) 18.66%	(-0.11) 18.95%	(19.01) 19.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
DIIs	(2.51) 2.56%	(0.01) 0.02%	(0.01) 0.02%	(0.01) 0.02%	(0.01) 0.02%	(0.01) 0.02%	(0.01) 0.02%	(0.01) 0.02%	(0.01) 0.02%	(0.01) 0.03%	(0.01) 0.03%	(0.01) 0.03%	(0.01) 0.03%	(0.01) 0.03%	(-19.01) 0.03%	(-0.31) 19.03%	(-0.21) 19.31%	(0.01) 19.48%	(0.01) 19.48%
Public	31.45%	32.24%	30.49%	25.12%	17.96%	17.50%	17.50%	17.11%	15.91%	10.18%	10.18%	10.18%	9.75%	8.33%	8.11%	8.11%	7.83%	7.64%	7.65%
No. of Shareholders	15,176	15,085	14,620	13,737	9,994	8,529	7,863	6,586	5,206	5,045	5,047	5,123	4,859	4,730	4,800	4,176	3,988	3,871	4,142

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	70.71	72.54	56.18	70.74	76.27	73.29	77.38	65.62	59.83	60.79	54.72	65.96	80.68	86.58	86.38	82.78	89.1	61.72	70.23	58.34
Sales Growth % (YoY)	-7.3%	-1%	-27.4%	7.8%	27.5%	20.6%	41.4%	-0.5%	-25.8%	-29.8%	-36.6%	-20.3%	-9.4%	40.3%	23%	41.9%	68.3%	-6.5%	16.4%	12.1%
Sales Growth % (QoQ)	-2.5%	29.1%	-20.6%	-7.3%	4.1%	-5.3%	17.9%	9.7%	-1.6%	11.1%	-17%	-18.2%	-6.8%	0.2%	4.3%	-7.1%	44.4%	-12.1%	20.4%	-
Expenses	70.59	69.45	55.02	66.58	63.72	69.3	66.79	55.53	46.36	47.14	43.96	57.12	67.93	71.29	71.63	69.02	77.88	48.16	56.2	46.95
Operating Profit	0.12	3.09	1.16	4.16	12.55	3.99	10.59	10.09	13.47	13.65	10.76	8.84	12.75	15.29	14.75	13.76	11.22	13.56	14.03	11.39
OPM %	0.17	4.26	2.06	5.88	16.45	5.44	13.69	15.38	22.51	22.45	19.66	13.4	15.8	17.66	17.08	16.62	12.59	21.97	19.98	19.52
Other Income	2.92	0.1	1.59	-1.78	-1.69	3.94	-4.11	-1.85	-0.7	1.51	5.93	-47.68	-0.22	-4.57	4.14	3.28	4.07	-0.4	0.13	1.17
Interest	0.99	1.02	0.89	1.01	0.74	1.38	0.45	0.37	0.61	0.41	0.37	0.29	0.27	0.01	0.02	0.2	0.1	0.02	0.01	0
Depreciation	0.65	0.56	0.48	0.46	0.46	0.48	0.46	0.49	0.67	0.48	0.66	0.29	1.19	0.19	0.19	0.19	0.17	0.16	0.12	0.07
Profit before tax	1.4	1.61	1.38	0.91	9.66	6.07	5.57	7.38	11.49	14.27	15.66	-39.42	11.07	10.52	18.68	16.65	15.02	12.98	14.03	12.49
Tax %	56.43	80.75	84.06	67.03	10.56	11.7	17.41	12.06	4.87	4.77	7.92	4.9	26.83	21.86	17.08	15.08	15.38	6.16	14.11	14.25
Net Profit	0.61	0.31	0.21	0.29	8.64	5.36	4.59	6.48	10.93	13.59	14.43	-41.34	8.1	8.23	15.49	14.15	12.71	12.18	12.05	10.71
Net Profit Growth % (QoQ)	96.8%	47.6%	-27.6%	-96.6%	61.2%	16.8%	-29.2%	-40.7%	-19.6%	-5.8%	134.9%	-610.4%	-1.6%	-46.9%	9.5%	11.3%	4.4%	1.1%	12.5%	-
Net Profit Growth % (YoY)	-92.9%	-94.2%	-95.4%	-95.5%	-21%	-60.6%	-68.2%	115.7%	34.9%	65.1%	-6.8%	-392.2%	-36.3%	-32.4%	28.5%	32.1%	-	-	-	-
TTM Net Profit	1.42	9.45	14.5	18.88	25.07	27.36	35.59	45.43	-2.39	-5.22	-10.58	-9.52	45.97	50.58	54.53	51.09	47.65	34.94	22.76	0
EPS in Rs	0.11	0.06	0.04	0.05	1.57	0.97	0.83	1.17	2.01	2.65	2.82	-8.07	1.59	1.64	3.1	2.83	2.54	2.44	2.41	2.14

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Sales	270	293	241	336	279	231	46	14
Sales Growth %	-7.6%	21.2%	-28.3%	20.4%	20.8%	407%	235.5%	-
Expenses	262	260	197	279	229	189	37	12
Operating Profit	9	32	45	57	51	43	8	2
OPM %	3	11	18	17	18	18	18	11
Other Income	3	2	-38	3	5	2	1	1
Interest	4	4	3	1	1	0	0	0
Depreciation	2	2	2	2	1	0	0	0
Profit before tax	5	29	2	57	55	44	9	2
Tax %	73	13	219	19	13	14	31	19
Net Profit	1	25	-2	46	48	38	6	2
Net Profit Growth %	-96%	1350%	-104.3%	-4.2%	26.3%	533.3%	200%	-
EPS in Rs	0.26	4.54	-0.44	9.03	9.53	7.63	1.22	1.3
Dividend Payout %	0	0	0	0	1	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash from Operating Activity	-4	-35	5	6	34	0	-14	-2
Cash from Investing Activity	-21	-22	-1	-11	-28	-6	0	0
Cash from Financing Activity	0	34	30	26	0	4	18	0
Net Cash Flow	-25	-23	34	21	6	-2	4	-2

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Equity Capital	11	11	11	11	11	10	10	10	10	3
Reserves	238	227	221	205	190	173	103	55	18	0
Borrowings	58	57	53	32	19	13	4	4	0	0
Other Liabilities	30	28	25	40	38	43	60	31	8	3
Total Liabilities	337	322	310	288	258	240	176	100	36	6
Fixed Assets	82	45	41	43	41	41	29	2	0	0
CWIP	0	34	22	0	2	3	1	0	0	0
Investments	0	0	0	0	0	0	0	3	0	0
Other Assets	255	244	247	245	215	195	147	94	36	6
Total Assets	337	322	310	288	258	240	176	100	36	6

Delivery

Delivery Data: BALAXI

#	Date	22 26% 27	Value (Cr)	Q/T 241	Del 72
1	4-Sep	25	0	235	88
2	3-Sep	26	1	209	71
3	2-Sep	25	1	363	66
4	1-Sep	23	0	174	85
5	31-Aug	22	0	184	74
6	28-Aug	23	0	141	80
7	27-Aug	22	0	74	88
8	26-Aug	22	0	89	66
9	25-Aug	23	0	87	79
10	24-Aug	23	0	135	80
11	21-Aug	22	0	279	91
12	20-Aug	22	0	231	86
13	19-Aug	24	0	292	94
14	18-Aug	24	0	224	96
15	17-Aug	24	0	228	98
16	14-Aug	24	0	211	97
17	13-Aug	24	0	409	99
18	12-Aug	24	0	133	98
19	11-Aug	24	0	172	96
20	10-Aug	24	0	224	78
21	7-Aug	24	0	133	83
22	6-Aug	24	0	183	72
23	5-Aug	24	0	255	45
24	4-Aug	24	0	231	94
25	3-Aug	24	0	116	99
26	31-Jul	24	0	115	97
27	30-Jul	25	0	200	64
28	29-Jul	24	0	110	80
29	28-Jul	24	0	200	95
30	27-Jul	24	0	78	83

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	141c	3c	1.77
03-Sep	144c	0	0

Stock Checklist

Price is above from 52 week high low average: 32%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

NseIndia | Trendlyne | Screener | TradingView